Literature DB >> 29551739

Factors That Affect Results of Psychometric Tests to Identify Patients With Minimal Hepatic Encephalopathy.

Maria Camila Pérez-Matos1, Z Gordon Jiang1, Elliot B Tapper2.   

Abstract

Of the clinical complications of cirrhosis, hepatic encephalopathy (HE) is the most devastating. HE is a spectrum of reversible cognitive changes ranging from minimal HE (MHE) (mild inattention and deficits of executive function) to overt HE (disorientation to coma). More than 40% of patients with cirrhosis develop HE, which increases mortality, falls, motor vehicle accidents, and has a significant psychosocial impact.1 Early recognition is crucial. Patients with cirrhosis are recommended to receive an assessment for MHE.2.
Copyright © 2018 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29551739      PMCID: PMC6139070          DOI: 10.1016/j.cgh.2018.03.010

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  7 in total

1.  Psychoactive Medications Increase the Risk of Falls and Fall-related Injuries in Hospitalized Patients With Cirrhosis.

Authors:  Elliot B Tapper; Yesenia Risech-Neyman; Neil Sengupta
Journal:  Clin Gastroenterol Hepatol       Date:  2015-03-26       Impact factor: 11.382

2.  Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver.

Authors:  Hendrik Vilstrup; Piero Amodio; Jasmohan Bajaj; Juan Cordoba; Peter Ferenci; Kevin D Mullen; Karin Weissenborn; Philip Wong
Journal:  Hepatology       Date:  2014-07-08       Impact factor: 17.425

3.  The animal naming test: An easy tool for the assessment of hepatic encephalopathy.

Authors:  Francesca Campagna; Sara Montagnese; Lorenzo Ridola; Marco Senzolo; Sami Schiff; Michele De Rui; Chiara Pasquale; Silvia Nardelli; Ilaria Pentassuglio; Carlo Merkel; Paolo Angeli; Oliviero Riggio; Piero Amodio
Journal:  Hepatology       Date:  2017-05-27       Impact factor: 17.425

4.  Physiologic dysfunction scores and cognitive function test performance in U.S. adults.

Authors:  Roni W Kobrosly; Christopher L Seplaki; Courtney M Jones; Edwin van Wijngaarden
Journal:  Psychosom Med       Date:  2011-12-07       Impact factor: 4.312

5.  Validation of the psychometric hepatic encephalopathy score (PHES) for identifying patients with minimal hepatic encephalopathy.

Authors:  Andrés Duarte-Rojo; José Estradas; Roberto Hernández-Ramos; Sergio Ponce-de-León; Juan Córdoba; Aldo Torre
Journal:  Dig Dis Sci       Date:  2011-04-03       Impact factor: 3.199

6.  Diagnosis of covert hepatic encephalopathy without specialized tests.

Authors:  Eiman Nabi; Leroy R Thacker; James B Wade; Richard K Sterling; R Todd Stravitz; Michael Fuchs; Douglas M Heuman; Iliana Bouneva; Arun J Sanyal; Mohammad S Siddiqui; Velimir Luketic; Melanie B White; Pamela Monteith; Nicole A Noble; Ariel Unser; Jasmohan S Bajaj
Journal:  Clin Gastroenterol Hepatol       Date:  2013-12-19       Impact factor: 11.382

7.  Diagnosis of Minimal Hepatic Encephalopathy Using Stroop EncephalApp: A Multicenter US-Based, Norm-Based Study.

Authors:  Sanath Allampati; Andres Duarte-Rojo; Leroy R Thacker; Kavish R Patidar; Melanie B White; Jagpal S Klair; Binu John; Douglas M Heuman; James B Wade; Christopher Flud; Robert O'Shea; Edith A Gavis; Ariel B Unser; Jasmohan S Bajaj
Journal:  Am J Gastroenterol       Date:  2015-12-08       Impact factor: 10.864

  7 in total
  6 in total

1.  Cognitive Function, Sarcopenia, and Inflammation Are Strongly Associated with Frailty: A Framingham Cohort Study.

Authors:  Manaav Mehta; Jeremy Louissaint; Neal S Parikh; Michelle T Long; Elliot B Tapper
Journal:  Am J Med       Date:  2021-08-28       Impact factor: 4.965

Review 2.  Changing Epidemiology of Cirrhosis and Hepatic Encephalopathy.

Authors:  Jeremy Louissaint; Sasha Deutsch-Link; Elliot B Tapper
Journal:  Clin Gastroenterol Hepatol       Date:  2022-08       Impact factor: 13.576

3.  Predicting Overt Hepatic Encephalopathy for the Population With Cirrhosis.

Authors:  Elliot B Tapper
Journal:  Hepatology       Date:  2019-05-10       Impact factor: 17.425

4.  Minimal Hepatic Encephalopathy and Mild Cognitive Impairment Worsen Quality of Life in Elderly Patients With Cirrhosis.

Authors:  Jasmohan S Bajaj; Andres Duarte-Rojo; Jesse J Xie; Chathur Acharya; James B Wade; Carlos Robles; Leroy R Thacker; Christopher Flud; Andrew Fagan; Mauricio Garcia-Saenz-de-Sicilia; Melanie B White; Megan Kelly; Vy Nguyen; Edith A Gavis; Hugo E Vargas
Journal:  Clin Gastroenterol Hepatol       Date:  2020-03-20       Impact factor: 11.382

5.  Association of chronic liver disease with cognition and brain volumes in two randomized controlled trial populations.

Authors:  Elora Basu; Manaav Mehta; Cenai Zhang; Chen Zhao; Russell Rosenblatt; Elliot B Tapper; Neal S Parikh
Journal:  J Neurol Sci       Date:  2021-12-23       Impact factor: 3.181

6.  Incidence and Bedside Predictors of the First Episode of Overt Hepatic Encephalopathy in Patients With Cirrhosis.

Authors:  Elliot B Tapper; Lilli Zhao; Samantha Nikirk; Jad Baki; Neehar D Parikh; Anna S Lok; Akbar K Waljee
Journal:  Am J Gastroenterol       Date:  2020-12       Impact factor: 12.045

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.